Linked Life Data

21254664

Source:http://linkedlifedata.com/resource/pubmed/id/21254664

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-21
pubmed:abstractText
Disodium cromoglycate (DSCG) is a compound commonly used in the treatment of allergic diseases. The effect of DSCG is due to its ability to stabilize the mast cell membrane and to prevent release of histamine and inflammatory mediators. Mast cells are also an abundant source of tissue metalloproteinases, serine proteases and growth factors, which play an important role in the processes of the tissue remodeling. In this view the DSCG is a substance which allows us to study the mechanisms of the pulmonary vascular bed remodeling in the experimental animals exposed to chronic hypoxia and in a phase of the recovery from hypoxia.
pubmed:language
cze
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1210-6313
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
21-3
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
[Disodium cromoglycate--mast cell degranulation blocker in the process of tissue remodelation].
pubmed:affiliation
Ustav patologické fyziologie, 2. LF UK, Praha. hana.maxova@lfmotol.cuni.cz
pubmed:publicationType
Journal Article, In Vitro, English Abstract